Trxade Health Inc. (NASDAQ: MEDS) Q1 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company focused on optimizing drug procurement and patient engagement. It...
Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company focused on optimizing drug procurement and patient engagement. It...
Pfizer Inc. (NYSE: PFE) reported first quarter 2022 earnings results today. Total revenues increased 77% year-over-year to $25.7 billion. Reported...
Eli Lilly and Company (NYSE: LLY) has reported higher earnings and revenues for the first quarter of 2022. The numbers...
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported a decline in first-quarter earnings despite a double-digit growth in...
Abbott (NYSE: ABT) today reported its first-quarter financial results for the period ended March 31, 2022. GAAP net earnings for...
Johnson & Johnson (NYSE: JNJ) reported first-quarter 2022 financial results before the regular market hours on Tuesday. The pharmaceutical giant...
AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported higher earnings for the third quarter of 2022 when the medical device maker’s...
Cronos Group Inc. (NASDAQ: CRON) has reported a wider net loss for the fourth quarter of 2021, despite a double-digit...
Tilray (NASDAQ: TLRY) reported third-quarter 2022 financial results before the regular market hours on Wednesday. Total net revenue increased 23%...
Can you briefly talk about your business model and the value you add to the market? Trxade (NASDAQ: MEDS) is...
The pandemic had a mixed impact on the healthcare sector. The high demand for COIVD care services sent medical facilities...
Cannabis producer HEXO Corp. (NASDAQ: HEXO) has reported a wider net loss for the second quarter of 2022. However, the...
Cipher Pharmaceuticals, Inc. ( TSX: CPH) Q4 2021 earnings call dated Mar. 18, 2022 Corporate Participants: Craig Mull — Interim Chief Executive...
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been busy enhancing its capabilities in healthcare delivery lately, through various initiatives including...
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) Q4 2021 earnings call dated Mar. 15, 2022 Corporate Participants: Judy DiClemente — Investor Relations Nikhil Lalwani — President...
After starting the year on a high note, the IPO market is currently going through a slow phase mainly due...
Meihua International Medical Technologies is the latest healthcare company to seek Wall Street listing, even as the IPO market picks...
Aurora Cannabis, Inc. (NYSE: ACB) on Thursday reported a narrower net loss for the second quarter of 2022. The company’s...
Cannabis producer Canopy Growth Corporation (NASDAQ: CGC) reported a narrower net loss for the third quarter of 2022, despite an...
Pfizer Inc. (NYSE: PFE) reported fourth quarter 2021 earnings results today. Revenues doubled year-over-year to $23.8 billion. Excluding contributions from...
The biomedical industry grew at an accelerated pace in 2021 even as healthcare systems went into overdrive amidst the COVID-induced...